A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : GMP / good manufacturing practice

[Related PubMed/MEDLINE]
Total Number of Papers: 645
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   GMP  (>> Co-occurring Abbreviation)
Long Form:   good manufacturing practice
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Adipose tissue-derived mesenchymal stromal cells for clinical application: An efficient isolation approach. MSCs
2019 Adipose-tissue-derived therapeutic cells in their natural environment as an autologous cell therapy strategy: the microtissue-stromal vascular fraction. SVF
2019 An exploratory analysis of U.S. FDA Class I medical device recalls: 2014-2018. ---
2019 Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up. DDD, MSCs, ODI, VAS
2019 Case study: The characterization and implementation of dielectric spectroscopy (biocapacitance) for process control in a commercial GMP CHO manufacturing process. CHO, LOQ
2019 Clinical Translation of [68Ga]Ga-NOTA-anti-MMR-sdAb for PET/CT Imaging of Protumorigenic Macrophages. CT, PET, sdAb, TAM
2019 Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord, and chorionic plate under serum-free condition. AM, BM, CP, MSCs, SCM, SFM, UC
2019 Cord-Blood-Stem-Cell-Derived Conventional Dendritic Cells Specifically Originate from CD115-Expressing Precursors. CB, CB-DCs, DCs, Mo
2019 Diagnostic HER2-binding radiopharmaceutical, [68Ga]Ga-ABY-025, for routine clinical use in breast cancer patients. HER2
10  2019 Ethanol content in traditionally fermented ayurvedic formulations: Compromised Good Manufacturing Practice regulations - compromised health. ---
11  2019 GMP-compatible manufacturing of three iPS cell lines from human peripheral blood. GMP-hiPSC, hiPSCs
12  2019 Good manufacturing practices of minimally processed vegetables reduce contamination with pathogenic microorganisms. FD, RTE
13  2019 Human serum enhances the proliferative capacity and immunomodulatory property of MSCs derived from human placenta and umbilical cord. FBS, HS, MSCs, PL-MSCs
14  2019 Human Stem Cells Promote Liver Regeneration After Partial Hepatectomy in BALB/C Nude Mice. MSCs
15  2019 Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells. CAR-T
16  2019 Incidence of spoilage fungi in the air of bakeries with different hygienic status. ---
17  2019 IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System. GLP, HSCs, IND, TCR
18  2019 Manufacturing of human Wharton's jelly stem cells for clinical use: selection of serum is important. ECM, FBS, HPL, HS, hWJSCs
19  2019 Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions. MSCs, VEGF
20  2019 Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis. HD, SSc, SVF
21  2019 Perspectives on trace chemical safety and chemophobia: risk communication and risk management. EDC, VOC
22  2019 Perspectives on trace chemical safety and chemophobia: risk communication and risk management. EDC, VOC
23  2019 Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data. BM, CFU-F, MNCs, MSCs, WBCs
24  2018 1H-NMR and MALDI-TOF MS as metabolomic quality control tests to classify platelet derived medium additives for GMP compliant cell expansion procedures. ASC, MALDI-TOF MS
25  2018 A bioreactor system for the manufacture of a genetically modified Plasmodium falciparum blood stage malaria cell bank for use in a clinical trial. GAP, MCB
26  2018 A comparative assessment of continuous production techniques to generate sub-micron size PLGA particles. PLGA
27  2018 A protocol to isolate and qualify purified human preantral follicles in cases of acute leukemia, for future clinical applications. MFC
28  2018 A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials. ---
29  2018 Achieving "Zero" Defects for Visible Particles in Injectables. PDA, PMF
30  2018 An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination. DC, HLA, IFN-gamma, MPLA, mRNA, PGE2, TNF-alpha
31  2018 Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications. BM-MSCs, MSCs
32  2018 Characterization of the animal by-product meal industry in Costa Rica: Manufacturing practices through the production chain and food safety. MBM
33  2018 Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approach. GTMPs, PEI
34  2018 Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity. ATMP, CIK, FBS, HPP, HS
35  2018 Development of a novel one-step production system for injectable liposomes under GMP. Lipo-CsA
36  2018 Development of Capacitance Tools: At-Line Method for Assessing Biomass of Mammalian Cell Culture and Fixed Cell Calibration Standard. ---
37  2018 Development of Inducible CD19-CAR T Cells with a Tet-On System for Controlled Activity and Enhanced Clinical Safety. CAR, iCAR19
38  2018 Differentiation of MSC and annulus fibrosus cells on genetically engineered silk fleece-membrane-composites enriched for GDF-6 or TGF-beta3. GAG, GE, hAFC, hMSC, IVD
39  2018 Ensuring Product Quality, Consistency and Patient Supply over Time for a Large-Volume Biologic: Experience with Remicade. ---
40  2018 Establishing the Production of Male Schistosoma mansoni Cercariae for a Controlled Human Infection Model. ---
41  2018 Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method. CPC, Exo-CPC
42  2018 Fully automated zirconium-89 labeling and purification of antibodies. 89Zr, DFO, mAbs, PET
43  2018 Generation and testing of clinical-grade exosomes for pancreatic cancer. ---
44  2018 Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells. DLI, GVHD, GVL, MHC
45  2018 Genipin-Enhanced Fibrin Hydrogel and Novel Silk for Intervertebral Disc Repair in a Loaded Bovine Organ Culture Model. IVD
46  2018 GMP Production and Scale-Up of Adherent Neural Stem Cells with a Quantum Cell Expansion System. NSC, QCE
47  2018 GMP-Grade Manufacturing of T Cells Engineered to Express a Defined gammadeltaTCR. CAR-T
48  2018 Good Manufacturing Practice (GMP) Translation of Advanced Cellular Therapeutics: Lessons for the Manufacture of Erythrocytes as Medicinal Products. RBCs
49  2018 Heparin: role in protein purification and substitution with animal-component free material. ---
50  2018 HIV-Specific T Cells Generated from Naive T Cells Suppress HIV InVitro and Recognize Wide Epitope Breadths. HLA, HSCT
51  2018 How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment? IL, NK, PBMNCs
52  2018 Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice. BDNF, HD, hNSC, htt
53  2018 Human papilloma virus-specific T cells can be generated from naive T cells for use as an immunotherapeutic strategy for immunocompromised patients. EBV, HPV, IFN, IL, LPS
54  2018 Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience. FBS, MSCs, PL
55  2018 Human Synovial MSC Good Manufacturing Practices for Articular Cartilage Regeneration. ACI, MSCs
56  2018 Improved GMP compliant approach to manipulate lipoaspirates, to cryopreserve stromal vascular fraction, and to expand adipose stem cells in xeno-free media. ASC, CFU-F, DMSO, FBS, SRGF, SVF
57  2018 Interleukin-1 receptor antagonist-mediated neuroprotection by umbilical cord-derived mesenchymal stromal cells following transplantation into a rodent stroke model. CREB, IL-1ra, IV-hUMSCs, MSCs
58  2018 Large-scale expansion of Vgamma9Vdelta2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells. aAPCs, CAR, IL, PBMCs
59  2018 Manufacture of endothelial colony-forming progenitor cells from steady-state peripheral blood leukapheresis using pooled human platelet lysate. ECFCs, PB, PLT, VEGF, WBC
60  2018 Molecular Imaging of Radiolabeled Bispecific T-Cell Engager 89Zr-AMG211 Targeting CEA-Positive Tumors. 89Zr, BiTE, CEA
61  2018 Multiproduct Resin Reuse for Clinical and Commercial Manufacturing-Methodology and Acceptance Criteria. HETP, MRR, PCLs
62  2018 Multivariate modeling of diffuse reflectance infrared fourier transform (DRIFT) spectra of mixtures with low-content polymorphic impurities with analysis of outliers. API, DRIFT, DRIFTS
63  2018 NK cell development in a human stem cell niche: KIR expression occurs independently of the presence of HLA class I ligands. HSPCs, KIRs, MSCs, NK
64  2018 Perineurium-like sheath derived from long-term surviving mesenchymal stem cells confers nerve protection to the injured spinal cord. MSCs, SCI, SOD3
65  2018 Pharmacology of Recombinant Adeno-associated Virus Production. rAAV
66  2018 Pilot Production of Mesenchymal Stem/Stromal Freeze-Dried Secretome for Cell-Free Regenerative Nanomedicine: A Validated GMP-Compliant Process. ---
67  2018 Plastic Scintillator-Based Microfluidic Devices for Miniaturized Detection of Positron Emission Tomography Radiopharmaceuticals. PET
68  2018 Proceedings of the 2017 Viral Clearance Symposium, Session 1.2: Upstream Mitigation, Part 2-Virus Barrier Filter and HTST. HTST, MMV
69  2018 Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications. BM, BM-hMSCs, HCELL, hMSCs, mRNA, RTK
70  2018 Quality control programmes for veterinary antimicrobial medicines. AMR, EU, EU-MS, MAH, WHO
71  2018 Quality of medicines: Deficiencies found by Brazilian Health Regulatory Agency (ANVISA) on good manufacturing practices international inspections. ---
72  2018 Recent Regulatory Trends in Pharmaceutical Manufacturing and their Impact on the Industry. ---
73  2018 Robust Revascularization in Models of Limb Ischemia Using a Clinically Translatable Human Stem Cell-Derived Endothelial Cell Product. CLI, hESC-ECP
74  2018 Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone. DCs, IL-1beta, TNF-alpha
75  2018 Specificity of Good Manufacturing Practice (GMP) for Biomedical Cell Products. BMCP
76  2018 The simultaneous isolation of multiple high and low frequent T-cell populations from donor peripheral blood mononuclear cells using the major histocompatibility complex I-Streptamer isolation technology. MHC
77  2018 The Turkish Medicines and Medical Devices Agency: Comparison of Its Registration Process with Australia, Canada, Saudi Arabia, and Singapore. CPP, GRevP, HSA, NAS, SFDA, TGA
78  2018 Tips and Tricks for Validation of Quality Control Analytical Methods in Good Manufacturing Practice Mesenchymal Stromal Cell Production. ATMPs, MSC
79  2018 Topical otic drugs in a multi-purpose manufacturing facility: a guide on determination and application of permitted daily exposure (PDE). APIs, EMA, MSC, PDE
80  2018 Trehalose to cryopreserve human pluripotent stem cells. CPAs, CS10, DMSO, EG, ER, GLY, hPSCs, lt-NES
81  2018 Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes. AAV
82  2018 Utility of routine evaluation of sterility of cellular therapy products with or without extensive manipulation: Best practices and clinical significance. ATMPs, BM, HSCT
83  2018 [Development of Large Scale Silkworm-rearing Technologies for the GMP Production of Biologics]. ---
84  2018 [Single-use Medical Devices Re-processing: Risk Assessment and Quality Control Technologies]. SUD
85  2017 A feasible, economical, and accurate analytical method for simultaneous determination of six alkaloid markers in Aconiti Lateralis Radix Praeparata from different manufacturing sources and processing ways. DDAs, MDAs, PCA, SSDMC
86  2017 A high-content small molecule screen identifies novel inducers of definitive endoderm. DE, hESCs, hiPSCs, mESCs, ROCKi
87  2017 A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes. ACT, TILs
88  2017 Acute and repeated dose (28 days) toxicity studies in rats and dogs of recombinant batroxobin, a snake venom thrombin-like enzyme expressed from Pichia pastoris. GLP, MTD, NIH, SD
89  2017 Adipose Stem Cell Function Maintained with Age: An Intra-Subject Study of Long-Term Cryopreserved Cells. ASC, SVF
90  2017 An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series. AGO, CDC, DOJ, DS, FDA, FTC, NDI
91  2017 Animal component-free Agrobacterium tumefaciens cultivation media for better GMP-compliance increases biomass yield and pharmaceutical protein expression in Nicotiana benthamiana. PAM, YEB
92  2017 Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications. AS, PADH
93  2017 Autologous Tenocyte Injection for the Treatment of Chronic Recalcitrant Gluteal Tendinopathy: A Prospective Pilot Study. ATI, MRI, OHS, SF-36, VAS
94  2017 Automated freeze-thaw cycles for decellularization of tendon tissue - a pilot study. ---
95  2017 Biomonitoring of arsenic in woodworkers exposed to CCA and evaluation of other non-occupational sources in Uruguay. CCA
96  2017 Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis. UC
97  2017 Comparison of food colour regulations in the EU and the US: a review of current provisions. ---
98  2017 Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer. BCR, WHO
99  2017 Cultivation of Human Oral Mucosal Explants on Contact Lenses. CK, CL, FCS, HS, OM
100  2017 Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic options. allo-HSCT, CMV